Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Mr. K who wrote (1846)	1/15/1999 9:56:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 6039

wonder if this company is in trials off to work can't check now we should research this company and see if it is early stage if so, might not get approval for a couple years curtis

To: Mr. K who wrote (1846)	1/15/1999 11:56:00 PM
From: chirodoc	Respond to of 6039

here is the whole article--most important part is the last sentence <<<<But the project is still at an early stage and it will be years before it will replace mammography, Fenster said ......2 years from now coii should have been approved for 1 1/2 years. quite a head start!!!! Thursday January 14 2:59 AM ET New Cancer Scanner May Avoid Need For Biopsies LONDON (Reuters) - A revolutionary imaging device developed by a U.S. scientist could offer a less traumatic means of cancer screening, avoiding the need for painful biopsies. The three-dimensional imaging technique -- called Hall Effect Imaging (HEI) -- uses electronic emissions to spot differences between healthy and diseased tissue, New Scientist magazine said Wednesday. ''What I'm hoping to have is something as sensitive and specific as MRI (magnetic resonance imaging) but with the speed of ultrasound,'' the inventor, Han Wen, based at the National Institutes of Health in Maryland, told the magazine. Breast cancer tumors give off a different electrical signal to healthy tissue. The new imaging technique uses ultrasonic emissions to highlight those differences. ''Some published results suggest that breast tumors trigger large changes in tissue electrical parameters,'' Wen said. The technique should work with other cancers since this change occurs in all other tumors, he added. Aaron Fenster, director of imaging at the Robarts Research Institute at the University of Western Ontario in Canada, told New Scientist that HEI had an advantage over existing techniques because it could rule out false positive tests. Up to now, the only way to make totally sure was a biopsy. But the project is still at an early stage and it will be years before it will replace mammography, Fenster said